Physician profile
Brian Sou
NPI 1235692021
$4,358.17
in general payments reported to CMS, 2019-2025
10 companies · $1,374 in 2025
The $1,374 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $40.64 · 2024: $2,943 · 2025: $1,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,801 · Travel and Lodging: $1,522 · Education: $35.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,800.79 |
| Travel and Lodging | $1,521.76 |
| Education | $35.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,598.62 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $1,594.84 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Painteq LLC | $411.55 | 2024 | Painteq |
| Nevro Corp. | $275.69 | 2024 | Senza |
| Saluda Medical Americas, INC. | $167.58 | 2025 | Evoke |
| Spr Therapeutics, INC | $102.58 | 2025 | Sprint Pns System |
| Abbvie INC. | $71.83 | 2024-2025 | |
| Globus Medical, INC. | $52.11 | 2025 | Senza |
| Si-Bone, INC. | $47.75 | 2024 | |
| Biotronik Nro, INC. | $35.62 | 2025 | Prospera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Sou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.